Variant report

Variant	esv3323180
Chromosome Location	chr2:10150026-10152874
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:56)
CpG islands
(count:122)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:56 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr2:10152585-10153024	GM12878	blood:	n/a	n/a
2	BCL3	chr2:10151871-10152581	GM12878	blood:	n/a	n/a
3	BCL3	chr2:10150641-10151806	GM12878	blood:	n/a	n/a
4	BCL3	chr2:10152261-10153031	GM12878	blood:	n/a	n/a
5	BCL3	chr2:10150872-10151542	GM12878	blood:	n/a	n/a
6	BHLHE40	chr2:10150215-10150255	HepG2	liver:	n/a	n/a
7	CTCF	chr2:10152131-10152139	GM19239	blood:	n/a	n/a
8	CTCF	chr2:10152141-10152211	GM19239	blood:	n/a	n/a
9	CTCF	chr2:10152411-10152483	GM19239	blood:	n/a	n/a
10	EP300	chr2:10148723-10151084	SK-N-SH	brain:	n/a	n/a
11	FOS	chr2:10152693-10152991	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr2:10152700-10152973	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr2:10152690-10152973	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr2:10152621-10152992	MCF10A-Er-Src	breast:	n/a	n/a
15	MAX	chr2:10151433-10152214	HCT-116	colon:	n/a	n/a
16	MAX	chr2:10151433-10152217	HCT-116	colon:	n/a	n/a
17	MAX	chr2:10150146-10150601	HepG2	liver:	n/a	chr2:10150331-10150340
18	MAZ	chr2:10150310-10150418	HepG2	liver:	n/a	chr2:10150331-10150340
19	MXI1	chr2:10150232-10150378	HepG2	liver:	n/a	n/a
20	MYC	chr2:10151896-10151956	H1-hESC	embryonic stem cell:	n/a	n/a
21	MYC	chr2:10152457-10152483	MCF-7	breast:	n/a	n/a
22	MYC	chr2:10152514-10152781	MCF-7	breast:	n/a	n/a
23	MYC	chr2:10152487-10152513	MCF-7	breast:	n/a	n/a
24	PBX3	chr2:10152241-10152367	GM12878	blood:	n/a	n/a
25	PBX3	chr2:10150622-10151497	GM12878	blood:	n/a	n/a
26	PBX3	chr2:10151964-10152916	GM12878	blood:	n/a	n/a
27	POLR2A	chr2:10151328-10151467	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr2:10152024-10153013	GM12892	blood:	n/a	n/a
29	POLR2A	chr2:10151563-10152011	HCT-116	colon:	n/a	n/a
30	POLR2A	chr2:10150778-10151697	GM12892	blood:	n/a	n/a
31	POU2F2	chr2:10152035-10152832	GM12891	blood:	n/a	n/a
32	POU2F2	chr2:10152050-10152928	GM12891	blood:	n/a	n/a
33	POU2F2	chr2:10150777-10151728	GM12891	blood:	n/a	n/a
34	RFX5	chr2:10150163-10150512	HepG2	liver:	n/a	n/a
35	RFX5	chr2:10149946-10150668	IMR90	lung:	n/a	n/a
36	RFX5	chr2:10148813-10150803	SK-N-SH	brain:	n/a	n/a
37	RXRA	chr2:10150044-10150456	HepG2	liver:	n/a	chr2:10150273-10150287
38	RXRA	chr2:10149948-10150629	HepG2	liver:	n/a	chr2:10150273-10150287
39	SP1	chr2:10151442-10152318	HCT-116	colon:	n/a	n/a
40	SP1	chr2:10151520-10152141	HCT-116	colon:	n/a	n/a
41	SP1	chr2:10152809-10153643	HCT-116	colon:	n/a	n/a
42	STAT3	chr2:10152740-10152950	MCF10A-Er-Src	breast:	n/a	n/a
43	STAT3	chr2:10152734-10152992	MCF10A-Er-Src	breast:	n/a	n/a
44	STAT3	chr2:10152705-10152990	MCF10A-Er-Src	breast:	n/a	n/a
45	TCF3	chr2:10152346-10152806	GM12878	blood:	n/a	n/a
46	TCF3	chr2:10151058-10151199	GM12878	blood:	n/a	n/a
47	TCF3	chr2:10150544-10156535	GM12878	blood:	n/a	chr2:10156466-10156482 chr2:10156466-10156481 chr2:10156469-10156478
48	USF1	chr2:10150216-10150455	HepG2	liver:	n/a	chr2:10150334-10150345
49	USF1	chr2:10151444-10152325	HCT-116	colon:	n/a	n/a
50	USF1	chr2:10151446-10152119	HCT-116	colon:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:10150780-10150830	HEEpiC	esophagus:	n/a
2	chr2:10150780-10150830	MCF10A-Er-Src	breast:	n/a
3	chr2:10152012-10152062	HCF	heart:	n/a
4	chr2:10150780-10150830	HIPEpiC	eye:	n/a
5	chr2:10150780-10150830	GM12892	blood:	n/a
6	chr2:10152012-10152062	ovcar-3	ovarian:	n/a
7	chr2:10152012-10152062	AG04450	lung:	fetal
8	chr2:10152012-10152062	HCM	heart:	n/a
9	chr2:10150780-10150830	NT2-D1	testis:	n/a
10	chr2:10152012-10152062	GM06990	blood:	n/a
11	chr2:10150780-10150830	HEK293	kidney:	embryo
12	chr2:10150780-10150830	AG04449	skin:	fetal
13	chr2:10150780-10150830	HepG2	liver:	n/a
14	chr2:10150780-10150830	SK-N-SH_RA	brain:	n/a
15	chr2:10150780-10150830	T-47D	breast:	n/a
16	chr2:10152012-10152062	SAEC	small airway:	n/a
17	chr2:10150780-10150830	MCF-7	breast:	n/a
18	chr2:10152012-10152062	NH-A	brain:	n/a
19	chr2:10152012-10152062	AG09309	skin:	n/a
20	chr2:10152012-10152062	GM12891	blood:	n/a
21	chr2:10152012-10152062	HNPCEpiC	eye:	n/a
22	chr2:10150780-10150830	ECC-1	luminal epithelium:	n/a
23	chr2:10152012-10152062	HCPEpiC	choroid plexus:	n/a
24	chr2:10150780-10150830	NH-A	brain:	n/a
25	chr2:10150780-10150830	PrEC	prostate:	n/a
26	chr2:10150780-10150830	SK-N-SH	brain:	n/a
27	chr2:10152012-10152062	NHDF-neo	bronchial:	n/a
28	chr2:10152012-10152062	HEEpiC	esophagus:	n/a
29	chr2:10152012-10152062	HIPEpiC	eye:	n/a
30	chr2:10152012-10152062	HRCEpiC	kidney:	n/a
31	chr2:10150780-10150830	HUVEC	blood vessel:	n/a
32	chr2:10150780-10150830	Hela-S3	cervix:	n/a
33	chr2:10152012-10152062	ECC-1	luminal epithelium:	n/a
34	chr2:10150780-10150830	BE2_C	brain:	n/a
35	chr2:10152012-10152062	Caco-2	colon:	n/a
36	chr2:10152012-10152062	HepG2	liver:	n/a
37	chr2:10150780-10150830	LNCaP	prostate:	n/a
38	chr2:10152012-10152062	SK-N-MC	brain:	n/a
39	chr2:10152012-10152062	CMK	blood:	n/a
40	chr2:10152012-10152062	H1-hESC	embryonic stem cell:	embryo
41	chr2:10150780-10150830	A549	lung:	n/a
42	chr2:10150780-10150830	AG10803	skin:	n/a
43	chr2:10152012-10152062	AoSMC	blood vessel:	n/a
44	chr2:10152012-10152062	PANC-1	pancreas:	n/a
45	chr2:10150780-10150830	HCT-116	colon:	n/a
46	chr2:10150780-10150830	Hepatocyte	liver:	n/a
47	chr2:10150780-10150830	SAEC	small airway:	n/a
48	chr2:10150780-10150830	NHDF-neo	bronchial:	n/a
49	chr2:10152012-10152062	SKMC	muscle:	n/a
50	chr2:10150780-10150830	GM19239	blood:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:10148714..10150676-chr2:10152229..10153770,2	MCF-7	breast:
2	chr2:10149097..10150727-chr2:10180461..10182958,2	MCF-7	breast:
3	chr2:10147491..10150465-chr2:10152525..10155691,3	MCF-7	breast:
4	chr2:10147171..10148722-chr2:10150073..10151791,3	K562	blood:
5	chr2:10143972..10145495-chr2:10148319..10150993,2	K562	blood:
6	chr2:10152022..10153719-chr2:10160507..10163452,2	MCF-7	breast:
7	chr2:10148500..10150133-chr2:10169876..10172659,2	K562	blood:
8	chr2:10147491..10150465-chr2:10152525..10155691,3	MCF-7	breast:
9	chr2:10148714..10150676-chr2:10152229..10153770,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000188525	TF binding region
ENSG00000188525	CpG island
ENSG00000260077	chromatin interactions
ENSG00000260476	chromatin interactions

Extended variants
information (count: 203 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:203 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184379342	chr2:10150086-10150087	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs567247333	chr2:10150092-10150093	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs114638194	chr2:10150095-10150096	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs113034187	chr2:10150128-10150129	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs28683516	chr2:10150141-10150142	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs35551114	chr2:10150214-10150215	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs397751654	chr2:10150215-10150216	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs143982855	chr2:10150269-10150270	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs538481836	chr2:10150274-10150275	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs368108831	chr2:10150333-10150334	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs147307864	chr2:10150334-10150335	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs78382160	chr2:10150346-10150347	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs113383810	chr2:10150354-10150355	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs559072575	chr2:10150364-10150365	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs112973813	chr2:10150365-10150366	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs139964302	chr2:10150410-10150411	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs562803700	chr2:10150450-10150451	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs112987523	chr2:10150453-10150454	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs116107594	chr2:10150461-10150462	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs564912703	chr2:10150464-10150465	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs527409045	chr2:10150541-10150542	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs373357604	chr2:10150550-10150551	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs547535100	chr2:10150554-10150555	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs386643072	chr2:10150560-10150561	Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs181276434	chr2:10150630-10150631	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs183915077	chr2:10150634-10150635	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs569574495	chr2:10150657-10150658	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs149844439	chr2:10150679-10150680	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs558360247	chr2:10150709-10150710	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs571530416	chr2:10150714-10150715	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs534091042	chr2:10150720-10150721	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs551185870	chr2:10150734-10150735	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs113185280	chr2:10150764-10150765	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs530634979	chr2:10150775-10150776	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs368030148	chr2:10150821-10150822	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs371481693	chr2:10150838-10150839	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs115473848	chr2:10150839-10150840	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs542659743	chr2:10150856-10150857	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs556270680	chr2:10150858-10150859	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs10929627	chr2:10150859-10150860	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs544950406	chr2:10150862-10150863	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs12995412	chr2:10150867-10150868	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs527493512	chr2:10150888-10150889	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs541182273	chr2:10150893-10150894	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs561014252	chr2:10150911-10150912	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs529807377	chr2:10150915-10150916	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs11686461	chr2:10150929-10150930	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs374159596	chr2:10150934-10150935	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs11686463	chr2:10150937-10150938	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs569529747	chr2:10150948-10150949	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Mental retardation	17847001	CNVD
Glioblastoma multiforme	21080181	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Cancer	20164920	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Glioma	17123091	CNVD
Breast cancer	20409316	CNVD
Multiple myeloma	16616336	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD

Chromatin state (count:126 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:10134800-10150600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr2:10139800-10150400	Weak transcription	Brain Inferior Temporal Lobe	brain
3	chr2:10141600-10160200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr2:10145800-10151000	Enhancers	Pancreas	Pancrea
5	chr2:10146400-10150800	Enhancers	Colon Smooth Muscle	Colon
6	chr2:10146400-10150800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr2:10146400-10151200	Enhancers	Placenta	Placenta
8	chr2:10146800-10150200	Enhancers	Rectal Smooth Muscle	rectum
9	chr2:10146800-10150800	Enhancers	Duodenum Smooth Muscle	Duodenum
10	chr2:10146800-10150800	Enhancers	HSMM	muscle
11	chr2:10146800-10151000	Enhancers	NHDF-Ad	bronchial
12	chr2:10146800-10151200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr2:10147000-10150600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr2:10147000-10150800	Enhancers	HSMMtube	muscle
15	chr2:10147200-10150600	Weak transcription	Esophagus	oesophagus
16	chr2:10147200-10150800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr2:10147200-10151200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr2:10147600-10151000	Enhancers	NHLF	lung
19	chr2:10147800-10151200	Enhancers	Fetal Muscle Leg	muscle
20	chr2:10148200-10151000	Enhancers	Ovary	ovary
21	chr2:10148200-10151800	Enhancers	Lung	lung
22	chr2:10148400-10150200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr2:10148400-10151200	Enhancers	Right Ventricle	heart
24	chr2:10148800-10153000	Weak transcription	Placenta Amnion	Placenta Amnion
25	chr2:10149000-10150800	Enhancers	Breast Myoepithelial Primary Cells	Breast
26	chr2:10149000-10150800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr2:10149200-10150200	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
28	chr2:10149200-10150400	Enhancers	Liver	Liver
29	chr2:10149200-10150600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr2:10149200-10151000	Enhancers	Colonic Mucosa	Colon
31	chr2:10149200-10151000	Enhancers	Left Ventricle	heart
32	chr2:10149200-10151000	Enhancers	Right Atrium	heart
33	chr2:10149200-10151000	Enhancers	Osteobl	bone
34	chr2:10149200-10151600	Enhancers	Spleen	Spleen
35	chr2:10149200-10152000	Enhancers	Gastric	stomach
36	chr2:10149400-10150400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr2:10149400-10150800	Enhancers	Brain Anterior Caudate	brain
38	chr2:10149400-10150800	Bivalent Enhancer	Fetal Stomach	stomach
39	chr2:10149400-10150800	Enhancers	Psoas Muscle	Psoas
40	chr2:10149400-10151200	Enhancers	Duodenum Mucosa	Duodenum
41	chr2:10149600-10150400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
42	chr2:10149600-10150600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr2:10149600-10150600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr2:10149600-10150800	Enhancers	Sigmoid Colon	Sigmoid Colon
45	chr2:10149600-10150800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
46	chr2:10149600-10151000	Enhancers	Stomach Mucosa	stomach
47	chr2:10149600-10151200	Enhancers	Skeletal Muscle Female	skeletal muscle
48	chr2:10149600-10152400	Enhancers	Adipose Nuclei	Adipose
49	chr2:10149800-10150200	Weak transcription	Brain Substantia Nigra	brain
50	chr2:10149800-10150200	Weak transcription	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links